In a study from 2014, Park et al. [62] injected bone marrow stem cells (CD34+) into the vitreous, in various diseases leading to irreversible loss of vision (AMD two cases, retinitis pigmentosa one case, retinal vascular occlusion one case, and Stargardt two cases). The gene discussed is CD34; the disease is retinal vein occlusion.